![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2007 RNA Society A recoding element that stimulates decoding of UGA codons by Sec tRNA[Ser]Sec
1Department of Human Genetics, University of Utah, Salt Lake City, Utah 84112, USA 2Molecular Biology of Selenium Section, Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Reprint requests to: Michael T. Howard, Department of Human Genetics, University of Utah, 15 N 2030 E, Rm. 2100, Salt Lake City, Utah 84112, USA; e-mail: mhoward/at/genetics.utah.edu; fax: (801) 585-3910. Received January 18, 2007; Accepted March 14, 2007. This article has been cited by other articles in PMC.Abstract Selenocysteine insertion during decoding of eukaryotic selenoprotein mRNA requires several trans-acting factors and a cis-acting selenocysteine insertion sequence (SECIS) usually located in the 3′ UTR. A second cis-acting selenocysteine codon redefinition element (SRE) has recently been described that resides near the UGA-Sec codon of selenoprotein N (SEPN1). Similar phylogenetically conserved elements can be predicted in a subset of eukaryotic selenoprotein mRNAs. Previous experimental analysis of the SEPN1 SRE revealed it to have a stimulatory effect on readthrough of the UGA-Sec codon, which was not dependent upon the presence of a SECIS element in the 3′ UTR; although, as expected, readthrough efficiency was further elevated by inclusion of a SECIS. In order to examine the nature of the redefinition event stimulated by the SEPN1 SRE, we have modified an experimentally tractable in vitro translation system that recapitulates efficient selenocysteine insertion. The results presented here illustrate that the SRE element has a stimulatory effect on decoding of the UGA-Sec codon by both the methylated and unmethylated isoforms of Sec tRNA[Ser]Sec, and confirm that efficient selenocysteine insertion is dependent on the presence of a 3′-UTR SECIS. The variation in recoding elements predicted near UGA-Sec codons implies that these elements may play a differential role in determining the amount of selenoprotein produced by acting as controllers of UGA decoding efficiency. Keywords: selenocysteine, selenoprotein, SEPN1, readthrough, SRE, recoding INTRODUCTION Selenium is cotranslationally incorporated as the 21st amino acid selenocysteine into a subset of proteins in all three lineages of life (Bock et al. 1991; Rother et al. 2001; Hatfield and Gladyshev 2002). This is accomplished by the expansion of the genetic code to include a dual meaning for the codon UGA, either translational termination or selenocysteine insertion. It is generally believed that the evolutionary force driving the genetic code to accommodate selenocysteine is provided by the catalytic advantage conferred on enzymes when the sulfur of a catalytic cysteine site is replaced by selenium (Berry et al. 1992; Sun et al. 1999; Zhang et al. 2006). The lower pKa and redox potential of selenocysteine relative to cysteine produces a fully ionized and highly reactive group at physiological pH. Consequently, most known selenoproteins are oxidoreductases with selenocysteine in the active site. In eukaryotes, selenocysteine insertion requires a selenocysteine insertion sequence (SECIS) RNA element, usually located in the 3′ UTR, a SECIS-binding protein (SBP2), a selenocysteine-specific elongation factor (eEFSec), and the selenocysteine-charged Sec tRNA[Ser]Sec (Lee et al. 1989; Copeland and Driscoll 1999; Tujebajeva et al. 2000). In addition, the expression of a subset of selenoproteins has been shown to depend upon the levels of two Sec tRNA[Ser]Sec isoforms (differing by a single methyl group at U34) (Moustafa et al. 2001; Carlson et al. 2005). The ratio of Um34 to U34 Sec tRNA[Ser]Sec, which varies in response to available selenium levels (Diamond et al. 1993), may in part be responsible for the observed hierarchical expression of selenoproteins under selenium-limiting conditions. Recent evidence suggests that key events that prime mRNAs for selenocysteine decoding may occur in the nucleus as well as the cytoplasm (Papp et al. 2006; Small-Howard et al. 2006), although the nature of these nuclear events remain speculative. While our understanding of the trans-acting factors involved in SECIS recognition and selenocysteine insertion in eukaryotes is growing rapidly, the integral mechanism by which the SECIS acts from a distance with these factors to affect reprogramming of the ribosome and redefinition of UGA codons remains elusive. In one model, the SECIS structure recruits SBP2 and the eEFSec:Sec tRNA[Ser]Sec complex to the 3′ UTR of selenoprotein mRNAs. During decoding of the UGA-Sec codon, SBP2 brings eEFSec to the ribosome, causing a conformational change that triggers Sec tRNA[Ser]Sec decoding of the UGA codon. Alternatively, it has been proposed that SBP2 may be associated with ribosomes prior to interacting with the SECIS element, based on the observation that most cytoplasmic SBP2 are in association with ribosomes (for review, see Caban and Copeland 2006). In the latter case, the role of the SECIS might be to alter ribosome conformation by interacting with ribosome-bound SBP2 during UGA redefinition. In addition, the recent observation that the ribosomal protein L30 can also bind directly to the SECIS structure in competition with SBP2 has provoked the idea that L30 may act as a molecular switch to alter the SECIS (and possibly ribosome) conformation to affect the events leading to Sec tRNA[Ser]Sec decoding of UGA-Sec codons (Chavatte et al. 2005). Bacterial SECIS elements are known to occur immediately downstream from the UGA-Sec codon (Zinoni et al. 1990; Berg et al. 1991; Huttenhofer et al. 1996; Zhang and Gladyshev 2005). In a recent search to determine if eukaryotic cis-acting signals might also reside near UGA-Sec codons, it was discovered that phylogenetically conserved cis-acting selenocysteine codon redefinition elements, termed SREs, can be identified just downstream from a subset of UGA-Sec codons (Howard et al. 2005; M.T. Howard, unpubl.). An independent bioinformatic search for deeply conserved functional RNA secondary structures identified the same elements downstream from the eukaryotic Selenoprotein T and SEPN1 UGA-Sec codons (Pedersen et al. 2006). Although RNA stem–loop structures can be predicted near many eukaryotic UGA-Sec codons, there appears to be little similarity with other known aspects of the bacterial SECIS elements. The SEPN1 SRE consists of a highly conserved stem–loop structure that starts 6 nucleotides (nt) downstream from the UGA codon. Phylogenetic analysis and directed mutagenesis revealed the importance of the stem–loop structure in addition to the length and sequence of the spacer separating it from the UGA-Sec codon for efficient readthrough activity (Howard et al. 2005). The observation that the selenoprotein N SRE can stimulate readthrough of both UGA and UAG codons raised the possibility that at least one effect on readthrough could be due to stimulation of decoding by near cognate tRNAs rather than Sec tRNA[Ser]Sec. To determine the effect of the SRE on Sec tRNA[Ser]Sec decoding of UGA codons, we have modified a rabbit reticulocyte lysate translation system for efficient selenocysteine insertion. The results indicate that the SRE has a strong effect on selenocysteine insertion at the SEPN1 UGA-Sec codon, and confirm that only very low levels of selenocysteine incorporation occur in the absence of a functional SECIS element. These results strongly support our contention that selenocysteine insertion efficiency, and possibly regulation, is affected by UGA-Sec adjacent recoding elements. RESULTS Efficient selenocysteine insertion in rabbit reticulocyte lysates: The SRE and polyamines Previously published reports of UGA-Sec decoding in rabbit reticulocyte lysates (RRL) have revealed that SBP2 is the limiting factor for selenocysteine insertion, and that only the C-terminal 447 amino acids (SBP2-CT) are required for selenocysteine insertion activity (Mehta et al. 2004). Here, we adapt a similar RRL-based in vitro assay for efficient selenocysteine insertion to address the nature of the recoding event stimulated by the SEPN1 SRE at UGA-Sec codons. In short, UGA-decoding efficiency and specificity during translation of a bicistronic reporter mRNA was optimized by adjusting the levels of Mg++, spermidine, and SBP2 in Flexi-RRL obtained from Promega. A significant advantage of this system is the use of a bicistronic reporter vector, which allows for the maintenance and manipulation of the UGA and its native surrounding sequence context. A detailed protocol of the translation reaction mixture, RNA levels, incubation temperature, and determination of readthrough and selenocysteine insertion efficiency is outlined in Materials and Methods. T7 RNA transcripts were produced from p2lucUGA2 (Fig. 1A
Changing the UGA codon to UAG (UAGSECIS) reduced readthrough to <1% in the presence or absence of SBP2 (Fig. 1B Polyamine levels have been shown to affect translational termination in several studies using RRL translations (Hryniewicz and Vonder Haar 1983; Petros et al. 2005). Based on these observations and the presumption that selenocysteine insertion is in competition with translational termination, we tested the effect of increasing spermidine levels on readthrough efficiency and decoding of UGA codons as selenocysteine. Spermidine was added at increasing concentrations to RRL translations primed with the UGA2 RNA, UGA2SECIS, and UAGSECIS. SDS-PAGE analysis of [35S]methionine-labeled products demonstrated that the addition of up to 0.8 mM spermidine increased readthrough levels in all three mRNAs to differing extents (Fig. 2A–C
The effect of the SRE on readthrough efficiency was first analyzed by translation of T7 transcripts containing mutations in the SRE structure. The UGA2SECIS RNA and RNAs transcribed from p2lucUGA2SC2-1 (SC2-1SECIS) and p2lucUGA2SC2-3 (SC2-3SECIS) (Howard et al. 2005) were translated in RRL reactions into which increasing amounts of SBP2 were added (Fig. 3A
To determine if spermidine could directly affect selenocysteine insertion, [75Se] Sec tRNA[Ser]Sec (a mixture of both isoforms) was added to in vitro translations to selectively label proteins incorporating selenocysteine. The RNAs corresponding to UGA2SECIS, SC2-1SECIS, SC2-3SECIS, UGA2, SC2-1, or SC2-3 were added to selenium-labeled RRL reactions with (Fig. 4A
UGA decoding by two isoforms of Sec tRNA[Ser]Sec
Decoding of UGA-Sec codons is known to occur by two isoforms of Sec tRNA[Ser]Sec containing Um34 or lacking this methyl modification. These tRNAs differ from one another by the presence or absence of a methyl group on the ribosyl moiety of the anticodon wobble base, methylcarboxylmethyluridine (mcm5U), or methylcarboxymethyluridine-2′-O-methylribose (mcm5Um), respectively (for review, see Hatfield and Gladyshev 2002). The ability to separate these two isoforms by HPLC chromatography (Hatfield et al. 1991) allowed us to examine directly whether the SRE element was involved in the selection of one isoform over the other during decoding. In the above experiment (Fig. 4
Additional cis-acting recoding elements? The p2luc constructs used in the above experiments contain the UGA-Sec codon and 35 nt upstream of and 46 nt downstream from SEPN1 cloned between the Firefly and Renilla luciferase genes. In addition, a minimal 100 nt SEPN1 SECIS was inserted downstream from the termination codon, but upstream of the vector polyadenylation site. To determine if additional recoding sequences may have been inadvertently missed in these experiments, the SEPN1 coding sequence starting 100 nt upstream of the UGA-Sec codon through the entire 3′ UTR was cloned downstream from GFP in the pcDNA3.1/NT-GFP expression vector (see Fig. 6A
The results presented here strongly support that the UGA-Sec codon and a 3′ SECIS are the necessary cis-acting elements required to reprogram the ribosome for selenocysteine insertion, and that the SRE-recoding element acts as a modifier of UGA-Sec decoding by both isoforms of Sec tRNA[Ser]Sec. DISCUSSION The description of features common to eukaryotic SECIS elements has allowed for the bioinformatic recognition of probably most selenoprotein genes in humans and a number of other sequenced eukaryotic genomes (for review, see Gladyshev et al. 2004). The entire biosynthetic pathway that synthesizes selenocysteine on its tRNA has been determined recently in eukaryotes and archaea (Xu et al. 2006). Yet, despite these advances, the discovery of the selenocysteine-specific elongation factor (eEFSec) and proteins that can interact with both the ribosome and SECIS (SBP2 and L30), our understanding of the mechanism by which information is conveyed at a distance from the 3′ UTR to reprogram the ribosome during decoding of the UGA-Sec codon is incomplete. Here, we describe the ability of a second cis-acting RNA-recoding element to affect selenocysteine-insertion efficiency. The occurrence of this RNA signal nearby the UGA-Sec codon raises the intriguing possibility that this element interacts directly with components of the selenocysteine insertion machinery and/or the ribosome during UGA-Sec decoding. The observation that SEPN1 SRE can stimulate readthrough of UAG termination codons in cultured mammalian cells, when no cis-acting SECIS is present, supports the proposition that at least one role of the SRE is to reduce termination efficiency. However, in the RRL translation system utilized here, the omission of a SECIS element or exogenously added SBP2-CT revealed only very low levels of readthrough, <0.1% (see Figs. 1 Another example of stop-codon redefinition occurs in the MuLV retrovirus. The gag-pol polyprotein is produced by ribosomal readthrough of the gag UAG termination codon. UAG redefinition in this case is stimulated by a pseudoknot structure located 8 nt downstream from the UAG codon (Wills et al. 1991). RNA pseudoknots with similar spacing (typically, 7–9 nt) downstream from ribosomal frameshift sites are also well-known stimulators of programmed translational frameshifting (Brierley and Pennell 2001). A recent publication by Brierley and colleagues (Namy et al. 2006) presents structural data demonstrating that the IBV frameshift-stimulating pseudoknot blocks the ribosome RNA entrance tunnel and causes conformational changes that lead to a structural deformation of the P-site tRNA. It is possible that a similar effect of the SRE stem–loop or MuLV pseudoknot may inhibit translational termination by inducing a conformation that blocks either release factor access to the A site, peptidyl tRNA hydrolysis, or both. This model provides a feasible, albeit speculative, mechanistic explanation for the ability of some downstream structures to favor decoding over translational termination at UGA or UAG codons. The location of the SRE near the UGA codon raises the possibility that it may interact with the selenocysteine insertion machinery in addition to the ribosome during UGA decoding. In bacteria, the bSECIS stem–loop is located just 3′ to selenocysteine-encoding UGA codons, and is recognized directly by the bacterial elongation factor, SelB (Baron et al. 1993; Huttenhofer et al. 1996). Of interest is the observation that domain IV of bacterial SelB is directed to the RNA entrance cleft and, consequently, is in a position to interact directly with the RNA sequences or structures located downstream from the UGA codon (Leibundgut et al. 2005). Although the eukaryotic eEFSec equivalent structure has not been determined, this observation suggests a mechanism by which the SEPN1 SRE or other structures occurring near selenocysteine-encoding UGA codons could potentially interact directly with eEFSec. Finally, it is possible that the SRE may interact directly with the RNA-binding proteins L30 or SBP2 when they are in association with either the ribosome or SECIS. In the latter case, such interactions could potentially act as a bridge to span the distance between the UGA-Sec codon and 3′ UTR. Identifying the components of the selenocysteine insertion machinery and/or ribosome that directly or indirectly interact with the SRE may provide key insights into the mechanism by which the 3′-UTR SECIS reprograms the ribosome during UGA decoding. The in vitro reconstitution of efficient UGA-Sec decoding described here will be a valuable tool in this pursuit. The findings presented herein clearly demonstrate a stimulatory role for the SEPN1 SRE during selenocysteine insertion. The results also preclude a model in which the SRE selectively recruits one Sec tRNA[Ser]Sec isoform over the other. The variation in occurrence and lack of obvious sequence or structural similarity between structures predicted near UGA-Sec codons suggests that these elements may play a differential role in controling selenoprotein expression at the translation level, and may even be regulatory in nature. A thorough survey of the effect on selenocysteine decoding by other potential selenoprotein SREs is underway. MATERIALS AND METHODS Luciferase and GFP fusion vectors The construction of p2lucUGA2, SC2-1, and SC2-3 with and without SECIS has been previously described (Howard et al. 2005). In brief, the following sequences from the selenoprotein N gene were cloned between the BamHI and SalI sites of the p2luc plasmid (Grentzmann et al. 1998), and the SEPN1 SECIS was inserted into the NotI site downstream from the termination codon. The UGA-Sec codon is indicated in bold, and mutations in the stem–loop region are shaded.
SEPN1 NTGFP T7 expression vectors were constructed using pcDNA3.1/NTGFP obtained from Invitrogen. SEPN1 sequences, nucleotides 1235–4109, were PCR amplified from a cDNA clone and ligated by TA cloning in frame with GFP coding sequences of pcDNA3.1/NTGFP (numbering based on SEPN1 Refseq NM206926). This clone was designated NTGFP SEPN1. SEPN1 deletions and directed mutagenesis of the SRE was accomplished using the PCR mutagenesis Phusion kit (New England Biolabs).
All changes were sequenced verified at the Sequencing Core Facility (University of Utah). T7 RNA transcription T7 RNA transcripts were produced using the MEGAScrip kit as described by the manufacturer (Ambion). Likewise, capped T7 transcripts were produced using the mMESSAGE mMACHINE kit (Ambion). Linear DNA templates were produced by restriction digestion of p2lucUGA2, SC2-1, and SC2-1 with Pml-1 or Hpa-1. Pml-1 cuts 5′ of the SECIS and, consequently, RNAs transcribed from this template lack a SECIS. Hpa-1 cuts 3′ of the SECIS, thus allowing for SECIS containing RNA transcripts to be produced. Constructs based on pcDNA3.1/NTGFP were linearized with NotI before addition to T7 transcription reactions. Isolation of [75Se]-labeled Sec tRNA[Ser]Sec
HL-60 cells were grown as described (Hatfield et al. 1991) in the presence of 5 × 10−7 M sodium selenite. Five grams of cells were washed and resuspended in 80 mL of fresh RPMI growth medium consisting of 1% fetal calf serum without selenium supplementation. Five millicuries of neutralized [75Se] (University of Missouri Research Reactor) were added, the cells gently shaken for 3 h at 37°C, and cyclohexamide (1 × 10−4 M) was then added and shaken for an additional 45 min. The cells were collected by centrifugation at 800 rpm for 5 min at 4°C, washed with cold medium, and the packed cells stored at −80°C until ready for use. Phenol extraction and subsequent purification of the labeled Sec tRNA[Ser]Sec isoforms by RPC-5 chromatography were carried out as described (Hatfield et al. 1991). In vitro translation Flexi Rabbit Reticulocyte Lysate containing 2.54 mM endogenous magnesium was obtained from Promega. The endogenous magnesium level is an important factor to consider, as increasing the amount of magnesium was shown to increase nonspecific readthrough efficiency (data not shown). In vitro translation reactions labeled with L-[35S]methionine contained 70% Flexi RRL, 0.02 mM of each standard amino acid except methionine, 6 μCi of [35S]methionine (GE HealthCare), 75 mM KCl, 2 mM DTT, 10 μg/mL RNA, and the indicated amount of exogenously added SBP2-CT and spermidine in a final volume of 10 μL. Reactions were incubated for 1.5 h at 30°C. For in vitro translation reactions labeled with [75Se], the conditions were identical, except that all 20 standard amino acids were added to 0.02 mM, and 10,000 cpm of [75Se] Sec tRNA[Ser]Sec were added in place of [35S]methionine. Reactions were stopped by the addition of RNase A to 10 μg/mL, and incubation continued for 15 min at room temperature. A total of 5 μL of each reaction was added to 25 μL of 1X SDS loading dye (50 mM Tris-Cl at pH 6.8, 2% SDS, 10% Glycerol, 100 mM DTT) and incubated at 80°C for 4 min; 10 μL were then loaded onto a 4%–12% Bis-Tris gradient gel (Invitrogen) and electrophoresis carried out as recommended by the manufacturer. Gels were fixed in 30% methanol and 5% glycerol for 15 min and dried under vacuum at 80°C. After drying under vacuum, the gels were visualized using a Storm 860 PhosphorImager (Molecular Dynamics) and radioactive bands quantified using ImageQuant software. Percent readthrough was calculated as the percentage of full-length product relative to the termination product and the full-length product combined. The value of each product was corrected for the number of methionine codons present in the coding sequence. Each experiment was repeated at least three times; a representative experiment is shown. pET101 containing the coding sequence for SBP2-CT (amino acids 399–846) was transformed into Escherichia coli BL21 Star (Promega). Bacterial cultures were grown at 37°C to an OD600 of 0.8 in 1 L of Luria Broth containing 100 μg/mL of Ampicillin (Sigma). Protein expression was induced by the addition of isopropyl-B-D-thiogalactoside (Sigma) and incubation continued for 2 h. Cells were harvested, washed with PBS, and lysed by six rounds of sonication on ice for 10 sec each. Cell lysates were centrifuged at 12,000 rpm for 30 min. The resulting clarified lysates were purified by Ni++ affinity chromatography, desalted, and stored at −20°C in phosphate buffered saline and 50% glycerol. ACKNOWLEDGMENTS We thank the Donna Driscoll's laboratory for SBP2 and L30 expression vectors and helpful advice during the purification of SBP2. Dolph Hatfield, John Atkins, and Ray Gesteland provided stimulating discussions and support throughout the course of this work. This research was supported by grant R01GM077462 to M.T.H. and in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research. Footnotes Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.473907. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Trends Biochem Sci. 1991 Dec; 16(12):463-7.
[Trends Biochem Sci. 1991]Biofactors. 2001; 14(1-4):75-83.
[Biofactors. 2001]Mol Cell Biol. 2002 Jun; 22(11):3565-76.
[Mol Cell Biol. 2002]Endocrinology. 1992 Oct; 131(4):1848-52.
[Endocrinology. 1992]J Biol Chem. 1999 Aug 27; 274(35):24522-30.
[J Biol Chem. 1999]J Biol Chem. 1989 Jun 15; 264(17):9724-7.
[J Biol Chem. 1989]J Biol Chem. 1999 Sep 3; 274(36):25447-54.
[J Biol Chem. 1999]EMBO Rep. 2000 Aug; 1(2):158-63.
[EMBO Rep. 2000]Mol Cell Biol. 2001 Jun; 21(11):3840-52.
[Mol Cell Biol. 2001]J Biol Chem. 2005 Feb 18; 280(7):5542-8.
[J Biol Chem. 2005]Cell Mol Life Sci. 2006 Jan; 63(1):73-81.
[Cell Mol Life Sci. 2006]Nat Struct Mol Biol. 2005 May; 12(5):408-16.
[Nat Struct Mol Biol. 2005]Proc Natl Acad Sci U S A. 1990 Jun; 87(12):4660-4.
[Proc Natl Acad Sci U S A. 1990]J Biol Chem. 1991 Nov 25; 266(33):22386-91.
[J Biol Chem. 1991]RNA. 1996 Apr; 2(4):354-66.
[RNA. 1996]Bioinformatics. 2005 Jun 1; 21(11):2580-9.
[Bioinformatics. 2005]EMBO J. 2005 Apr 20; 24(8):1596-607.
[EMBO J. 2005]J Biol Chem. 2004 Sep 3; 279(36):37852-9.
[J Biol Chem. 2004]EMBO J. 2005 Apr 20; 24(8):1596-607.
[EMBO J. 2005]Mol Gen Genet. 1983; 190(2):336-43.
[Mol Gen Genet. 1983]Biochem Biophys Res Commun. 2005 Dec 23; 338(3):1478-89.
[Biochem Biophys Res Commun. 2005]EMBO J. 2005 Apr 20; 24(8):1596-607.
[EMBO J. 2005]Nucleic Acids Res. 1991 Feb 25; 19(4):939-43.
[Nucleic Acids Res. 1991]Annu Rev Nutr. 2004; 24():579-96.
[Annu Rev Nutr. 2004]PLoS Biol. 2007 Jan; 5(1):e4.
[PLoS Biol. 2007]Proc Natl Acad Sci U S A. 1991 Aug 15; 88(16):6991-5.
[Proc Natl Acad Sci U S A. 1991]Nature. 2006 May 11; 441(7090):244-7.
[Nature. 2006]Proc Natl Acad Sci U S A. 1993 May 1; 90(9):4181-5.
[Proc Natl Acad Sci U S A. 1993]RNA. 1996 Apr; 2(4):354-66.
[RNA. 1996]EMBO J. 2005 Jan 12; 24(1):11-22.
[EMBO J. 2005]EMBO J. 2005 Apr 20; 24(8):1596-607.
[EMBO J. 2005]RNA. 1998 Apr; 4(4):479-86.
[RNA. 1998]Nucleic Acids Res. 1991 Feb 25; 19(4):939-43.
[Nucleic Acids Res. 1991]